Search

GlaxoSmithKline PLC

Closed

Sector Healthcare

1,349.5 -0.07

Overview

Share price change

24h

Current

Min

1347

Max

1362.5

Recommendations

By TipRanks

Recommendations

Neutral

12 Months Forecast

+16.91 upside

Dividends

By Dow Jones

Next Earnings

5 Feb 2025

Next Dividend date

10 Apr 2025

Next Ex Dividend date

20 Feb 2025

News Sentiment

By Acuity

33%

67%

103 / 392 Healthcare

GlaxoSmithKline PLC Chart

Past performance is not a reliable indicator of future results.

Related News

13 Jan 2025, 07:14 UTC

Acquisitions, Mergers, Takeovers

GSK to Buy U.S. Rare Tumor Specialist IDRx for Up to $1.15 Billion

9 Jan 2025, 06:50 UTC

Acquisitions, Mergers, Takeovers

GSK in Talks to Buy U.S. Rare Tumor Specialist IDRx for up to $1 Billion, FT Says, Citing Sources

15 Nov 2024, 10:28 UTC

Major Market Movers

European Vaccine Makers Under Pressure After Trump Picks RFK Jr to Lead Health Department

30 Oct 2024, 11:44 UTC

Earnings

GSK Cuts Vaccine Sales Outlook Amid U.S. Weakness -- Update

30 Oct 2024, 07:50 UTC

Earnings

GSK Profit Rises on HIV, Cancer Treatments But Sales Slip on Weak U.S. Vaccine Demand

13 Jan 2025, 07:05 UTC

Acquisitions, Mergers, Takeovers

GSK Enters Agreement To Acquire IDRx, Inc. >GSK.LN

13 Jan 2025, 07:00 UTC

Acquisitions, Mergers, Takeovers

GSK to Buy U.S. Rare Tumor Specialist IDRx for Up to $1.15 Bln

13 Jan 2025, 07:00 UTC

Acquisitions, Mergers, Takeovers

GSK to Make $1B Upfront Payment

13 Jan 2025, 07:00 UTC

Acquisitions, Mergers, Takeovers

GSK to Buy IDRx for up to $1.15B

13 Jan 2025, 07:00 UTC

Acquisitions, Mergers, Takeovers

GSK: Acquisition Adds to Portfolio in Gastrointestinal Cancers

9 Jan 2025, 11:24 UTC

Market Talk

FDA Label Warning Threatens GSK's RSV Vaccine Sales -- Market Talk

9 Jan 2025, 06:35 UTC

Acquisitions, Mergers, Takeovers

GSK in Talks to Buy U.S. Rare Tumor Specialist IDRx for up to $1 Bln, FT Says, Citing Sources

15 Nov 2024, 13:08 UTC

Top News

Trump's RFK Pick Weighs on Vaccine Makers -- WSJ

15 Nov 2024, 10:34 UTC

Market Talk

Vaccine Sector Sell-Off Looks Overdone -- Market Talk

15 Nov 2024, 10:29 UTC

Hot Stocks

Stocks to Watch Friday: Tesla, Domino's, Palantir, Ulta -- WSJ

7 Nov 2024, 11:53 UTC

Top News
Earnings

Moderna Earnings Beat Estimates. But Its Future Still Looks Uncertain. -- Barrons.com

7 Nov 2024, 11:31 UTC

Earnings

Moderna Earnings Beat Estimates. But Its Future Still Looks Uncertain. -- Barrons.com

31 Oct 2024, 19:48 UTC

Top News

AstraZeneca Probe in China Adds to Concerns for Foreign Businesses -- Update

30 Oct 2024, 15:04 UTC

Market Talk
Earnings

GSK's 3Q Results Are a Mixed Bag -- Market Talk

30 Oct 2024, 08:22 UTC

Market Talk
Earnings

GSK's Vaccine Weakness Is a Major Concern -- Market Talk

30 Oct 2024, 07:18 UTC

Earnings

GSK Reiterates Guidance As HIV And Cancer Drug Demand Offset Vaccine Weakness -- MarketWatch

30 Oct 2024, 07:04 UTC

Earnings

GSK PLC Expects to deliver Around Middle of Existing Annual Guidance Ranges

30 Oct 2024, 07:03 UTC

Earnings

GSK PLC 3Q EPS 1.4p

30 Oct 2024, 07:02 UTC

Earnings

GSK PLC Had Seen 2024 Sales Growth of 7% to 9%

30 Oct 2024, 07:02 UTC

Earnings

GSK PLC Issues Dividend of 15p

30 Oct 2024, 07:01 UTC

Earnings

GSK PLC Had Seen 2024 Core Earnings Per Share Growth of 10% to 12%

30 Oct 2024, 07:01 UTC

Earnings

GSK PLC Had Seen 2024 Core Operating Pft Growth Between 11% and 13%

30 Oct 2024, 07:01 UTC

Earnings

GSK PLC Backs 2024 View

30 Oct 2024, 07:00 UTC

Earnings

Analysts Saw GSK PLC 3Q Net Pft GBP1.78B

30 Oct 2024, 07:00 UTC

Earnings

Analysts Saw GSK PLC 3Q Turnover GBP8.00B

GlaxoSmithKline PLC Forecast

Price Target

By TipRanks

16.91% upside

12 Months Forecast

Average 1,583 GBX  16.91%

High 2,355 GBX

Low 1,350 GBX

Based on 11 Wall Street analysts offering 12 month price targets forGlaxoSmithKline PLC - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

11 ratings

2

Buy

7

Hold

2

Sell

Sentiment

By Acuity

103 / 392 Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

$